-
2
-
-
84928593845
-
The myelodysplastic syndromes
-
In: Bennet, J.M., ed. New York: Marcel Dekker
-
Phelan JT, Kouides PA, Bennet JM. The myelodysplastic syndromes. In : Bennet JM, ed. Myelodysplastic Syndromes: Historical Aspects and Classification. New York : Marcel Dekker, 2002 1 14.
-
(2002)
Myelodysplastic Syndromes: Historical Aspects and Classification.
, pp. 1-14
-
-
Phelan, J.T.1
Kouides, P.A.2
Bennet, J.M.3
-
3
-
-
27644470560
-
Immune pathophysiology of aplastic anemia
-
Nakao S, Feng X, Sugimori C. Immune pathophysiology of aplastic anemia. Int J Hematol 2005 82 : 196 200.
-
(2005)
Int J Hematol
, vol.82
, pp. 196-200
-
-
Nakao, S.1
Feng, X.2
Sugimori, C.3
-
4
-
-
0037375709
-
Immunosuppressive treatments for myelodysplastic syndromes
-
Shimamoto T, Ohyashiki K. Immunosuppressive treatments for myelodysplastic syndromes. Leuk Lymphoma 2003 44 : 593 604.
-
(2003)
Leuk Lymphoma
, vol.44
, pp. 593-604
-
-
Shimamoto, T.1
Ohyashiki, K.2
-
5
-
-
0031452899
-
Peripheral blood picture in primary hypocellular refractory anemia and idiopathic acquired aplastic anemia: An additional tool for differential diagnosis
-
Elghetany MT, Hudnall SD, Gardner FH. Peripheral blood picture in primary hypocellular refractory anemia and idiopathic acquired aplastic anemia: An additional tool for differential diagnosis. Haematologica 1997 82 : 21 4.
-
(1997)
Haematologica
, vol.82
, pp. 21-4
-
-
Elghetany, M.T.1
Hudnall, S.D.2
Gardner, F.H.3
-
6
-
-
0035880236
-
Identification of myelodysplastic syndrome-specific genes by DNA microarray analysis with purified hematopoietic stem cell fraction
-
Miyazato A, Ueno S, Omine K et al. Identification of myelodysplastic syndrome-specific genes by DNA microarray analysis with purified hematopoietic stem cell fraction. Blood 2001 98 : 422 7.
-
(2001)
Blood
, vol.98
, pp. 422-7
-
-
Miyazato, A.1
Ueno, S.2
Omine, K.3
-
7
-
-
0142215552
-
DNA microarray analysis of stage progression mechanism in myelodysplastic syndrome
-
Ueda M, Ota J, Yamashita Y et al. DNA microarray analysis of stage progression mechanism in myelodysplastic syndrome. Br J Haematol 2003 123 : 288 96.
-
(2003)
Br J Haematol
, vol.123
, pp. 288-96
-
-
Ueda, M.1
Ota, J.2
Yamashita, Y.3
-
8
-
-
0035047755
-
Detection of diagnostically critical, often hidden, anomalies in complex karyotypes of haematological disorders using multicolour fluorescence in situ hybridization
-
Jalal SM, Law ME, Stamberg J et al. Detection of diagnostically critical, often hidden, anomalies in complex karyotypes of haematological disorders using multicolour fluorescence in situ hybridization. Br J Haematol 2001 112 : 975 80.
-
(2001)
Br J Haematol
, vol.112
, pp. 975-80
-
-
Jalal, S.M.1
Law, M.E.2
Stamberg, J.3
-
9
-
-
33645822948
-
Genomewide screening of DNA copy number changes in chronic myelogenous leukemia with the use of high-resolution array-based comparative genomic hybridization
-
Hosoya N, Sanada M, Nannya Y et al. Genomewide screening of DNA copy number changes in chronic myelogenous leukemia with the use of high-resolution array-based comparative genomic hybridization. Genes Chromosomes Cancer 2006 45 : 482 94.
-
(2006)
Genes Chromosomes Cancer
, vol.45
, pp. 482-94
-
-
Hosoya, N.1
Sanada, M.2
Nannya, Y.3
-
10
-
-
0032931517
-
The p53 pathway
-
Prives C, Hall PA. The p53 pathway. J Pathol 1999 187 : 112 26.
-
(1999)
J Pathol
, vol.187
, pp. 112-26
-
-
Prives, C.1
Hall, P.A.2
-
11
-
-
0036258111
-
The IRAC TP53 database: New online mutation analysis and recommendations to users
-
Olivier M, Eeles R, Hollstein M et al. The IRAC TP53 database: New online mutation analysis and recommendations to users. Hum Mutat 2002 19 : 607 14.
-
(2002)
Hum Mutat
, vol.19
, pp. 607-14
-
-
Olivier, M.1
Eeles, R.2
Hollstein, M.3
-
12
-
-
0030986849
-
No concomitant occurrence of the N-ras and p53 gene mutations in myelodysplastic syndromes
-
Mitani K, Hangaishi A, Imamura N et al. No concomitant occurrence of the N-ras and p53 gene mutations in myelodysplastic syndromes. Leukemia 1997 11 : 863 5.
-
(1997)
Leukemia
, vol.11
, pp. 863-5
-
-
Mitani, K.1
Hangaishi, A.2
Imamura, N.3
-
13
-
-
0030463176
-
TP53 mutations in myelodysplastic syndrome
-
Misawa S, Horiike S. TP53 mutations in myelodysplastic syndrome. Leuk Lymphoma 1996 23 : 417 22.
-
(1996)
Leuk Lymphoma
, vol.23
, pp. 417-22
-
-
Misawa, S.1
Horiike, S.2
-
14
-
-
27644590943
-
Discriminating functional and non-functional p53 in human tumours by p53 and MDM2 immunohistochemistry
-
Nenutil R, Smardova J, Pavlova S et al. Discriminating functional and non-functional p53 in human tumours by p53 and MDM2 immunohistochemistry. J Pathol 2005 207 : 251 9.
-
(2005)
J Pathol
, vol.207
, pp. 251-9
-
-
Nenutil, R.1
Smardova, J.2
Pavlova, S.3
-
15
-
-
0036050016
-
Significance of fetal hemoglobin-containing erythroblasts (F blasts) and the F blast/F cell ratio in myelodysplastic syndromes
-
Choi JW, Kim Y, Fujino M, Ito M. Significance of fetal hemoglobin-containing erythroblasts (F blasts) and the F blast/F cell ratio in myelodysplastic syndromes. Leukemia 2002 16 : 1478 83.
-
(2002)
Leukemia
, vol.16
, pp. 1478-83
-
-
Choi, J.W.1
Kim, Y.2
Fujino, M.3
Ito, M.4
-
16
-
-
0036546275
-
F-blast is a useful marker for differentiating hypocellular refractory anemia from aplastic anemia
-
Choi JW, Fujino M, Ito M. F-blast is a useful marker for differentiating hypocellular refractory anemia from aplastic anemia. Int J Hematol 2002 75 : 257 60.
-
(2002)
Int J Hematol
, vol.75
, pp. 257-60
-
-
Choi, J.W.1
Fujino, M.2
Ito, M.3
-
17
-
-
0030897009
-
International scoring system for evaluating prognosis in myelodysplastic syndromes
-
Greenberg P, Cox C, Le Beau MM et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997 89 : 2079 88.
-
(1997)
Blood
, vol.89
, pp. 2079-88
-
-
Greenberg, P.1
Cox, C.2
Le Beau, M.M.3
-
18
-
-
0036943071
-
F blast production correlates strongly with upregulation of inducible nitric oxide synthase in myelodysplastic syndromes
-
Choi JW, Kim Y, Fujino M, Ito M. F blast production correlates strongly with upregulation of inducible nitric oxide synthase in myelodysplastic syndromes. Ann Hematol 2002 81 : 548 50.
-
(2002)
Ann Hematol
, vol.81
, pp. 548-50
-
-
Choi, J.W.1
Kim, Y.2
Fujino, M.3
Ito, M.4
-
19
-
-
0033731787
-
P53 overexpression in bone marrow biopsies in refractory anemia and aplastic anemia: Impact of antibody selection
-
Elghetany MT. p53 overexpression in bone marrow biopsies in refractory anemia and aplastic anemia: Impact of antibody selection. Leuk Res 2000 24 : 975 7.
-
(2000)
Leuk Res
, vol.24
, pp. 975-7
-
-
Elghetany, M.T.1
-
20
-
-
0032888458
-
Study of p53 in elderly patients with myelodysplastic syndromes by immunohistochemistry and DNA analysis
-
Kikukawa M, Aoki N, Sakamoto Y, Mori M. Study of p53 in elderly patients with myelodysplastic syndromes by immunohistochemistry and DNA analysis. Am J Pathol 1999 155 : 717 21.
-
(1999)
Am J Pathol
, vol.155
, pp. 717-21
-
-
Kikukawa, M.1
Aoki, N.2
Sakamoto, Y.3
Mori, M.4
-
21
-
-
0032406577
-
Significance of p53 overexpression in bone marrow biopsies from patients with bone marrow failure: Aplastic anemia, hypocellular refractory anemia, and hypercellular refractory anemia
-
Elghetany MT, Vyas S, Yuoh G. Significance of p53 overexpression in bone marrow biopsies from patients with bone marrow failure: Aplastic anemia, hypocellular refractory anemia, and hypercellular refractory anemia. Ann Hematol 1998 77 : 261 4.
-
(1998)
Ann Hematol
, vol.77
, pp. 261-4
-
-
Elghetany, M.T.1
Vyas, S.2
Yuoh, G.3
-
22
-
-
7144264414
-
Hemoglobin F in myelodysplastic syndrome
-
Reinhardt D, Hasse D, Schoch C et al. Hemoglobin F in myelodysplastic syndrome. Ann Hematol 1998 76 : 135 8.
-
(1998)
Ann Hematol
, vol.76
, pp. 135-8
-
-
Reinhardt, D.1
Hasse, D.2
Schoch, C.3
-
23
-
-
0033989581
-
Increased HbF levels in dyserythropoiesis
-
Kudo S, Harigae H, Watanabe N et al. Increased HbF levels in dyserythropoiesis. Clin Chim Acta 2000 291 : 83 7.
-
(2000)
Clin Chim Acta
, vol.291
, pp. 83-7
-
-
Kudo, S.1
Harigae, H.2
Watanabe, N.3
-
24
-
-
39649094569
-
New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: Evidence from a core dataset of 2124 patients
-
Haase D, Germing U, Schanz J et al. New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: Evidence from a core dataset of 2124 patients. Blood 2007 110 : 4385 95.
-
(2007)
Blood
, vol.110
, pp. 4385-95
-
-
Haase, D.1
Germing, U.2
Schanz, J.3
-
25
-
-
39149083040
-
Hypocellularity in myelodysplastic syndrome is an independent factor which predicts a favorable outcome
-
Yue G, Hao S, Fadare O et al. Hypocellularity in myelodysplastic syndrome is an independent factor which predicts a favorable outcome. Leuk Res 2008 32 : 553 8.
-
(2008)
Leuk Res
, vol.32
, pp. 553-8
-
-
Yue, G.1
Hao, S.2
Fadare, O.3
-
26
-
-
33947710653
-
Hematopathological concepts and controversies in the diagnosis and classification of myelodysplastic syndromes
-
Vardiman JW. Hematopathological concepts and controversies in the diagnosis and classification of myelodysplastic syndromes. Hematology Am Soc Hematol Educ Program 2006 199 204.
-
(2006)
Hematology Am Soc Hematol Educ Program
, pp. 199-204
-
-
Vardiman, J.W.1
|